European regulators have given Singulex the CE mark for its Sgx Clarity cTnl assay for use in quantitative measurement of troponin. The assay, which is available on the company's Sgx Clarity fully automated in vitro diagnostic platform, is indicated to be used with clinical evaluation for ruling out cardiac ischemia in patients with suspected coronary artery disease.
EU approves troponin assay from Singulex
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.